Showing 51 - 60 of 84
Persistent link: https://www.econbiz.de/10005674240
Objectives The objective of this study was to evaluate the intended and unintended impact on pharmaceutical use and sales of three public reimbursement reforms applied to the prescription of statins: a Spanish generic reference pricing system, and two competing policies introduced by the...
Persistent link: https://www.econbiz.de/10008455656
Persistent link: https://www.econbiz.de/10001685148
Persistent link: https://www.econbiz.de/10002110162
Persistent link: https://www.econbiz.de/10002113527
Persistent link: https://www.econbiz.de/10002576693
Persistent link: https://www.econbiz.de/10003077215
Persistent link: https://www.econbiz.de/10002097681
This paper examines the impact of coinsurance exemption for prescription medicines applied to elderly individuals in Spain after retirement. To evaluate this coinsurance change we use a rich administrative dataset that links pharmaceutical consumption and hospital discharge records for the full...
Persistent link: https://www.econbiz.de/10014178520
This paper reviews the literature on reference pricing (RP) in pharmaceutical markets. The RP strategy for cost containment of expenditure on drugs is analyzed as part of the procurement mechanism. We review the existing literature and the state-of-the-art regarding RP by focusing on its...
Persistent link: https://www.econbiz.de/10014196006